Sign up to save your podcasts
Or
Share MDT perspectives on managing side effects associated with second-line treatment for SCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MDT perspectives on managing side effects associated with second-line treatment for SCLC
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life
The multidisciplinary team:
- Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
View all episodes
By touchpodcasttouchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life
The multidisciplinary team:
- Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/